147 related articles for article (PubMed ID: 27156192)
21. NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
Nichols JC; Schiffer CA; Royer WE
J Biol Chem; 2021; 296():100351. PubMed ID: 33524397
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Wang R; Zhang X; Song H; Zhou S; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
[TBL] [Abstract][Full Text] [Related]
23. The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets.
Bhambhani C; Chang JL; Akey DL; Cadigan KM
EMBO J; 2011 May; 30(10):2031-43. PubMed ID: 21468031
[TBL] [Abstract][Full Text] [Related]
24. Chloro-oxime derivatives as novel small molecule chaperone amplifiers.
Zhou Y; Vu K; Chen Y; Pham J; Brady T; Liu G; Chen J; Nam J; Murali Mohan Reddy PS; Au Q; Yoon IS; Tremblay MH; Yip G; Cher C; Zhang B; Barber JR; Ng SC
Bioorg Med Chem Lett; 2009 Jun; 19(11):3128-35. PubMed ID: 19398333
[TBL] [Abstract][Full Text] [Related]
25. Functional inactivation of a transcriptional corepressor by a signaling kinase.
Barnes CJ; Vadlamudi RK; Mishra SK; Jacobson RH; Li F; Kumar R
Nat Struct Biol; 2003 Aug; 10(8):622-8. PubMed ID: 12872159
[TBL] [Abstract][Full Text] [Related]
26. Coordinated histone modifications mediated by a CtBP co-repressor complex.
Shi Y; Sawada J; Sui G; Affar el B; Whetstine JR; Lan F; Ogawa H; Luke MP; Nakatani Y; Shi Y
Nature; 2003 Apr; 422(6933):735-8. PubMed ID: 12700765
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of α,β-Unsaturated Carbonyl-Based Compounds, Oxime and Oxime Ether Analogs as Potential Anticancer Agents for Overcoming Cancer Multidrug Resistance by Modulation of Efflux Pumps in Tumor Cells.
Qin HL; Leng J; Zhang CP; Jantan I; Amjad MW; Sher M; Naeem-Ul-Hassan M; Hussain MA; Bukhari SN
J Med Chem; 2016 Apr; 59(7):3549-61. PubMed ID: 27010345
[TBL] [Abstract][Full Text] [Related]
28. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
29. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
30. Incapacitating CtBP to kill cancer.
Zhao LZ; Chinnadurai G
Cell Cycle; 2010 Sep; 9(18):3645-6. PubMed ID: 20930508
[No Abstract] [Full Text] [Related]
31. CtBP represses Dpp signaling as a dimer.
Bi C; Meng F; Yang L; Cheng L; Wang P; Chen M; Fang M; Xie H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1980-1985. PubMed ID: 29225171
[TBL] [Abstract][Full Text] [Related]
32. CtBP contributes quantitatively to Knirps repression activity in an NAD binding-dependent manner.
Sutrias-Grau M; Arnosti DN
Mol Cell Biol; 2004 Jul; 24(13):5953-66. PubMed ID: 15199149
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel steroidal 5α,8α-epidioxyandrost-6-ene-3β-ol-17-(O-phenylacetamide)oxime derivatives as potential anticancer agents.
Bu M; Cao T; Li H; Guo M; Yang BB; Zeng C; Zhou Y; Zhang N; Hu L
Bioorg Med Chem Lett; 2017 Aug; 27(16):3856-3861. PubMed ID: 28666736
[TBL] [Abstract][Full Text] [Related]
34. Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer.
Dcona MM; Chougoni KK; Dcona DT; West JL; Singh SJ; Ellis KC; Grossman SR
Cancer Res Commun; 2023 Oct; 3(10):2003-2013. PubMed ID: 37707363
[TBL] [Abstract][Full Text] [Related]
35. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP.
Shen Y; Kapfhamer D; Minnella AM; Kim JE; Won SJ; Chen Y; Huang Y; Low LH; Massa SM; Swanson RA
Nat Commun; 2017 Sep; 8(1):624. PubMed ID: 28935892
[TBL] [Abstract][Full Text] [Related]
36. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
Stankovic-Valentin N; Verger A; Deltour-Balerdi S; Quinlan KG; Crossley M; Leprince D
FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein.
Byun JS; Park S; Yi DI; Shin JH; Hernandez SG; Hewitt SM; Nicklaus MC; Peach ML; Guasch L; Tang B; Wakefield LM; Yan T; Caban A; Jones A; Kabbout M; Vohra N; Nápoles AM; Singhal S; Yancey R; De Siervi A; Gardner K
Cell Death Dis; 2019 Sep; 10(10):689. PubMed ID: 31534138
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
[TBL] [Abstract][Full Text] [Related]
40. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.
Grooteclaes M; Deveraux Q; Hildebrand J; Zhang Q; Goodman RH; Frisch SM
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4568-73. PubMed ID: 12676992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
